Bmi Doctors

is semaglutide like saxenda 1

Is Semaglutide Like Saxenda? Full Guide to Effectiveness, Side Effects & Cost

by

Table of Contents

Introduction

In recent years, new medicines for weight management have gained a lot of attention. Among the most discussed are semaglutide and Saxenda. Both belong to a group of drugs called GLP-1 receptor agonists. These medicines were first designed for people with type 2 diabetes, but doctors later noticed they also helped with weight loss. This discovery led to new uses, and today they are prescribed not just for blood sugar control but also for obesity management.

Obesity is a major health challenge worldwide. It increases the risk of type 2 diabetes, heart disease, certain cancers, and many other medical problems. Traditional treatments like diet, exercise, and behavioral therapy often help, but for many people they are not enough. That is where medicines like semaglutide and Saxenda come in. They offer another tool to help people reach and maintain a healthier weight. Because they come from the same class of medications, people often ask whether they are the same or if one works better than the other.

At first glance, semaglutide and Saxenda seem similar. They both act on the same hormone system in the body and help reduce appetite. They are both given by injection and both require a doctor’s prescription. But there are also important differences in how they work, how often they are taken, their effectiveness, side effects, and cost. These differences matter when patients and healthcare providers are deciding which treatment might be the best fit.

The question “Is semaglutide like Saxenda?” is also one of the top search queries on the internet. Many people want to understand if these drugs are interchangeable or if one is clearly better. Others are curious about how long they need to take them, what the risks are, or if their insurance will pay for them. Because the answers can be confusing, this guide explains the science and the facts in clear, simple language.

Both semaglutide and Saxenda work by mimicking a natural hormone in the body called glucagon-like peptide-1, or GLP-1. This hormone helps regulate blood sugar and appetite. By acting on the brain and the digestive system, these medicines can make people feel full sooner and for longer. This leads to eating fewer calories and, over time, weight loss. But even though the mechanism is similar, the drugs are not identical. Saxenda contains liraglutide, while semaglutide is a newer drug with a stronger and longer-lasting effect.

One of the biggest reasons people compare them is effectiveness. Clinical studies show semaglutide usually leads to greater weight loss compared to Saxenda. For example, in some studies, patients taking semaglutide lost around 15% of their body weight over a little more than a year, while patients taking Saxenda lost closer to 5–8%. This difference has made semaglutide a more common choice in recent years, especially when the goal is significant weight reduction.

Another factor is how the drugs are taken. Saxenda requires a daily injection, while semaglutide can be given once a week by injection, or in some cases taken as a daily pill. This makes semaglutide more convenient for many people, since fewer injections usually mean better adherence to treatment.

However, no medicine is without risks. Both drugs can cause side effects, especially stomach-related issues like nausea, diarrhea, or constipation. These effects are usually strongest in the first weeks of treatment but can be bothersome enough that some people stop taking the medication. Doctors usually increase the dose slowly to help the body adjust.

Cost is another major concern. Both semaglutide and Saxenda are expensive if paid out-of-pocket, often costing more than $1,000 per month in the United States. Insurance coverage varies, and some plans will only cover one drug or neither. For many patients, cost is the deciding factor in whether they can stay on treatment long term.

The purpose of this article is to provide a full guide comparing semaglutide and Saxenda. It will explain how they work, who they are for, how effective they are, what side effects to expect, and how much they cost. Each section is designed to answer the most common questions people have when searching online about these drugs. By the end, readers should have a clear understanding of the similarities and differences, and why a doctor might recommend one over the other.

Weight management is not just about losing pounds on a scale. It is about improving health, lowering risk of chronic disease, and enhancing quality of life. Medicines like semaglutide and Saxenda are powerful tools that can help many people on this journey. Understanding how they compare is the first step in making informed choices about treatment.

Change Your Life Today For Only $249/month

Find out if you qualify
No Hidden Fees, No Contracts

What Are Semaglutide and Saxenda?

When people hear about new medications for weight loss, the names semaglutide and Saxenda often come up. Both are prescription medicines used to help with weight management. They belong to the same family of drugs called GLP-1 receptor agonists, but they are not exactly the same. To understand how they compare, it helps to look at what each drug is, how it was developed, and how it is used today.

What Is Semaglutide?

Semaglutide is a medicine first created to treat type 2 diabetes. It works by mimicking a natural hormone in the body called GLP-1 (glucagon-like peptide-1). This hormone helps control blood sugar and appetite. Because of this, semaglutide not only lowers blood sugar but also reduces hunger, which can lead to weight loss.

Semaglutide is available under several brand names, each with a different use:

  • Ozempic – an injection taken once a week, approved to lower blood sugar in type 2 diabetes, but it can also lead to weight loss.

  • Rybelsus – an oral tablet form, taken once daily for type 2 diabetes.

  • Wegovy – an injection taken once a week, specifically approved for chronic weight management in people who are overweight or obese.

Because of these different forms, semaglutide is flexible. Some people use it mainly for diabetes, while others take it for weight management. In recent years, Wegovy in particular has gained wide attention as one of the most effective weight loss medicines available.

What Is Saxenda?

Saxenda is another medicine in the GLP-1 receptor agonist family. Its active ingredient is liraglutide. Like semaglutide, liraglutide was first developed to help people with type 2 diabetes. The diabetes version of liraglutide is called Victoza, which is taken once daily. Later, researchers studied a higher dose of liraglutide for weight loss, and this form became Saxenda.

Saxenda is approved specifically for weight management in people with obesity or those who are overweight and also have weight-related health problems, such as high blood pressure, type 2 diabetes, or high cholesterol. Unlike semaglutide, Saxenda is not available in a pill form. It must be injected every day under the skin using a prefilled pen.

Similarities Between Semaglutide and Saxenda

Although they are different drugs, semaglutide and Saxenda have several similarities:

  1. Drug class – Both belong to the GLP-1 receptor agonist group. This means they act in a similar way inside the body.

  2. Effects on appetite – Both medicines reduce hunger, help people feel full sooner, and lower the urge to overeat.

  3. Weight management use – Both are approved for weight loss in people who meet certain health criteria.

  4. Injection-based forms – Both can be given by injection under the skin, though semaglutide also comes as a pill.

These similarities are the reason why many people wonder if semaglutide is the same as Saxenda.

Key Differences Between Semaglutide and Saxenda

Even though they work in similar ways, there are important differences that set them apart:

  1. Active ingredient – Semaglutide and liraglutide are two different compounds. They are in the same drug family but are not identical.

  2. How often you take them – Saxenda is injected once daily, while semaglutide (Wegovy or Ozempic) is injected only once weekly. Semaglutide tablets (Rybelsus) are taken once daily by mouth.

  3. FDA approvals – Saxenda is only approved for weight management. Semaglutide has multiple approvals: type 2 diabetes (Ozempic, Rybelsus) and chronic weight management (Wegovy).

  4. Effectiveness – Clinical studies show that semaglutide often leads to greater weight loss compared to Saxenda. On average, people lose more weight with semaglutide than with liraglutide.

  5. Dosing strength – Saxenda requires a higher dose of liraglutide to reach its effect. Semaglutide is more powerful, so smaller amounts are needed.

  6. Convenience – Because semaglutide can be taken weekly or as a pill, it is often considered easier to use compared to Saxenda’s daily injection.

Why Knowing the Difference Matters

Understanding these differences is important for people considering treatment. Both medicines can be very helpful, but one may be better suited than the other depending on a person’s health history, lifestyle, and weight goals.

For example:

  • Someone who struggles with daily injections may find weekly semaglutide injections easier to manage.

  • A person with type 2 diabetes who also needs to lose weight might benefit more from semaglutide because of its dual approval for diabetes and weight management.

  • On the other hand, someone who responds better to liraglutide or who has insurance coverage only for Saxenda may stay with that option.

Semaglutide and Saxenda are both part of the same drug class and share many similarities, but they are not the same medicine. Semaglutide is available under several brand names and can be taken weekly or even as a pill. Saxenda, with its active ingredient liraglutide, requires daily injections. Both are powerful tools for weight management, but they differ in convenience, effectiveness, and approved uses.

How Do They Work in the Body?

To understand how semaglutide and Saxenda (liraglutide) work, it helps to first look at the hormone system they are based on. Both medicines belong to a group called GLP-1 receptor agonists. GLP-1 stands for glucagon-like peptide-1. This is a natural hormone made in the gut after eating. Its job is to send signals to different parts of the body to help control blood sugar and appetite.

The Role of GLP-1 in the Body

When we eat, our intestines release GLP-1. This hormone has several important effects:

  1. It stimulates insulin release. Insulin helps lower blood sugar by moving glucose from the blood into cells for energy or storage.

  2. It reduces glucagon release. Glucagon is another hormone that raises blood sugar. By lowering glucagon, GLP-1 helps prevent sugar spikes.

  3. It slows stomach emptying. Food stays in the stomach longer, which makes you feel full and slows how quickly sugar enters the blood.

  4. It affects the brain. GLP-1 acts on areas of the brain that control hunger, reducing appetite and cravings.

The problem is that natural GLP-1 breaks down very quickly in the body. It only lasts a few minutes before being destroyed by enzymes. This limits how long it can help with appetite or blood sugar.

How Semaglutide and Saxenda Copy This Effect

Both semaglutide and liraglutide (the drug in Saxenda) are designed to “mimic” natural GLP-1 but last much longer. They are called receptor agonists because they attach to the same GLP-1 receptors in the body and trigger the same effects, just like the natural hormone would.

  • Semaglutide is built to be very stable. It resists the enzymes that break down GLP-1, so it stays active for about a week. That is why it can be given once weekly as an injection (Ozempic or Wegovy) or once daily in pill form (Rybelsus).

  • Liraglutide (Saxenda) is also resistant to breakdown but not as long-lasting. It usually lasts less than 24 hours, which is why it has to be injected every day.

Appetite Regulation and Weight Loss

One of the main reasons these medicines help with weight management is their effect on the brain. Both drugs act on the hypothalamus, a part of the brain that controls hunger and fullness. By activating GLP-1 receptors here, they:

  • Increase the feeling of satiety (fullness) after meals.

  • Lower cravings for high-calorie foods.

  • Reduce the overall desire to eat.

At the same time, slowing stomach emptying adds to this effect. People feel full longer after a meal, which leads to smaller portion sizes and fewer snacks. Over time, this creates a calorie deficit, which results in weight loss.

Differences in Duration of Action

Even though semaglutide and liraglutide act on the same receptor, their duration makes a difference in how they feel to patients:

  • With liraglutide (Saxenda), levels in the body rise and fall more quickly. This may mean steadier daily dosing is needed to keep appetite under control.

  • With semaglutide, the long half-life allows a single dose to work over seven days. The brain and gut receptors are activated more consistently without the daily peaks and dips.

Some studies suggest that this longer, more stable activation may partly explain why semaglutide has led to greater weight loss results in clinical trials compared to Saxenda.

Effects Beyond Weight

Both drugs also help with blood sugar control. This is why semaglutide is also used in type 2 diabetes treatment, and why liraglutide has a diabetes version called Victoza. By increasing insulin release only when blood sugar is high, and lowering glucagon, they reduce spikes after meals without causing dangerous low blood sugar on their own.

They may also have effects on the cardiovascular system. Clinical trials have shown GLP-1 receptor agonists can reduce the risk of heart attack and stroke in certain patients with diabetes and obesity. Research is still ongoing to understand these protective effects fully.

is semaglutide like saxenda 2

Which Is More Effective for Weight Loss?

When people compare semaglutide and Saxenda, the main question they ask is: Which medicine helps you lose more weight? Both are designed to help with long-term weight management. Both belong to the same drug family called GLP-1 receptor agonists. But there are important differences in how much weight loss they usually produce, how long they have been studied, and how people respond to them in the real world.

Clinical Trial Results: Head-to-Head Data

Clinical trials give us the best way to compare results because they track large groups of people under the same conditions.

  • Semaglutide (Wegovy):
     In the STEP-1 trial, people without diabetes who took semaglutide 2.4 mg once weekly lost an average of 14.9% of their body weight over 68 weeks. Some people lost even more—20% or higher.

  • Saxenda (liraglutide 3 mg daily):
     In the SCALE trial, people without diabetes who took Saxenda lost an average of 8% of their body weight over 56 weeks.

This means that, on average, semaglutide produced nearly double the weight loss compared to Saxenda in similar groups of patients.

Percentage of People Who Achieve Significant Weight Loss

It is also helpful to look at how many people achieve certain levels of weight loss:

  • With semaglutide, about 70% of participants lost at least 10% of their body weight, and around 50% lost 15% or more.

  • With Saxenda, about 35% lost 10% or more, and fewer than 20% lost 15% or more.

These numbers show that semaglutide is more likely to help people reach larger, clinically meaningful weight loss goals.

Duration of Studies and Timing of Results

Another difference is how long the studies lasted:

  • The semaglutide STEP-1 trial ran for 68 weeks (over one year and four months).

  • The Saxenda SCALE trial ran for 56 weeks (just over one year).

Both drugs show most of their weight loss effect in the first 3–6 months. After that, weight loss continues more slowly and then levels off. However, because semaglutide is longer-acting, it seems to sustain and build on weight loss a bit more strongly over time.

Real-World Adherence

In real life, patients do not always take medicine exactly as directed. Adherence can make a big difference in outcomes.

  • Semaglutide is taken once weekly as an injection (or once daily if in pill form at lower doses for diabetes). This weekly dosing makes it easier for many patients to stick with treatment.

  • Saxenda is taken once daily as an injection. Daily injections can be harder to remember, and some patients stop because it feels burdensome.

Because semaglutide is more convenient, people are often able to stay on it longer, which helps improve overall results in practice.

Tolerability and Dropout Rates

Both medicines can cause side effects like nausea, vomiting, or diarrhea. These side effects can lead some people to stop taking the medication.

  • Studies show that dropout rates are slightly lower with semaglutide than with Saxenda. One reason may be that the once-weekly injection of semaglutide is easier to tolerate compared to the daily injections of Saxenda.

  • However, some people still find semaglutide difficult, especially at the higher weight loss dose (2.4 mg weekly).

When people stop either drug, they usually regain some or all of the weight they lost. This means that staying on treatment is very important for maintaining results.

Individual Response Differences

It is important to remember that not everyone responds the same way.

  • Some people lose a large amount of weight with Saxenda, while others lose very little.

  • The same is true for semaglutide, even though average results are higher.

Doctors often start with one medicine and may switch to another if the results are not strong enough, or if side effects are too difficult.

What Are the Side Effects of Semaglutide vs Saxenda?

Every medicine has benefits and risks. Semaglutide and Saxenda both help with weight loss and blood sugar control, but they can also cause side effects. Since these two medicines work in a similar way, many of their side effects overlap. Still, the frequency and severity can differ depending on which one a person takes. Below is a detailed look at what patients may experience.

Common Side Effects

The most common side effects of both semaglutide and Saxenda are related to the digestive system. These occur because GLP-1 receptor agonists slow down how quickly food leaves the stomach and affect appetite centers in the brain.

  • Nausea – Many people feel queasy when first starting treatment. For some, this may last only a few days, while for others it can continue for weeks. Clinical studies show nausea is the number one reason people stop taking these medicines.

  • Vomiting – Less common than nausea, but still reported. It often improves as the body gets used to the medication.

  • Diarrhea – Loose stools and frequent bathroom trips can happen, especially in the early weeks.

  • Constipation – Interestingly, some people experience the opposite problem. Both Saxenda and semaglutide can slow digestion enough to cause constipation.

  • Abdominal pain – Stomach discomfort, bloating, or cramping may occur.

Most of these symptoms are mild to moderate. Doctors usually start patients at a lower dose and increase it slowly (a process called titration) to reduce these effects.

Serious But Less Common Side Effects

Both semaglutide and Saxenda carry warnings for more serious conditions. While these are rare, it is important for patients to be aware of them.

  1. Pancreatitis

    • Inflammation of the pancreas can cause severe upper abdominal pain, nausea, and vomiting.

    • Both drugs include warnings about this risk. If pancreatitis is suspected, the medicine must be stopped right away.

  2. Gallbladder Problems

    • Rapid weight loss itself increases the risk of gallstones.

    • Both Saxenda and semaglutide may raise this risk further. Symptoms can include pain in the right upper abdomen, fever, and jaundice (yellowing of the skin or eyes).

  3. Kidney Issues

    • Severe dehydration from vomiting or diarrhea may stress the kidneys. Rarely, this can lead to kidney injury.

    • Staying hydrated is especially important for patients on these medicines.

  4. Thyroid Tumors (in animals)

    • In rodent studies, both liraglutide (Saxenda) and semaglutide have been linked to thyroid C-cell tumors.

    • While this has not been proven in humans, the FDA requires a strong warning. People with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2) should not take these drugs.

  5. Hypoglycemia (Low Blood Sugar)

    • When used alone, semaglutide and Saxenda rarely cause low blood sugar.

    • But the risk increases if the patient is also taking insulin or other diabetes medicines that lower blood glucose.

Comparing Side Effect Profiles

Although both medicines cause similar side effects, studies suggest differences in how often they happen.

  • Semaglutide – Because it is stronger and works longer in the body, semaglutide tends to cause nausea and gastrointestinal upset in a slightly higher percentage of patients. However, many people tolerate the once-weekly dosing better than a daily injection.

  • Saxenda (liraglutide) – Daily injections mean the drug is present in smaller amounts at a time. This can lead to somewhat lower rates of nausea, but since patients inject every day, the burden of treatment can feel greater.

Discontinuation rates (patients stopping the drug due to side effects) are significant for both medicines. In clinical trials:

  • Around 5–10% of patients on Saxenda stopped treatment because of side effects.

  • For semaglutide, about 7–12% discontinued for the same reasons.

Managing Side Effects

Doctors and patients can take steps to make treatment easier:

  • Start low, go slow – Increasing the dose gradually helps the body adjust.

  • Eat smaller meals – Large, greasy, or spicy meals often make nausea worse.

  • Stay hydrated – This prevents dehydration from vomiting or diarrhea.

  • Report persistent symptoms – If side effects are severe or long-lasting, a dose adjustment or medication change may be needed.

Both semaglutide and Saxenda share a similar side effect profile because they belong to the same drug class. The most frequent issues are nausea, vomiting, diarrhea, constipation, and abdominal pain. Rare but serious risks include pancreatitis, gallbladder disease, kidney problems, and possible thyroid tumors. Semaglutide may cause gastrointestinal side effects in more patients, but its once-weekly dosing can make it easier to live with compared to Saxenda’s daily injection.

Ultimately, side effects vary from person to person. Some tolerate one drug better than the other. Doctors carefully weigh these risks against the benefits of weight loss and improved health before recommending either treatment.

Change Your Life Today For Only $249/month

Find out if you qualify
No Hidden Fees, No Contracts

Who Is Eligible to Take Them?

Medications like semaglutide and Saxenda (liraglutide) are not designed for everyone. They are powerful prescription drugs, and doctors use specific rules to decide who can take them safely. Eligibility depends on a person’s body mass index (BMI), medical conditions, age, and health history. Below is a full breakdown of who may qualify and who should not take these medicines.

BMI and Weight Criteria

The main group that qualifies for these medicines are people with overweight or obesity. Doctors often use BMI to measure this.

  • BMI of 30 or higher: This means a person is considered to have obesity. Anyone with this BMI may qualify for semaglutide or Saxenda, even if they do not have other health problems.

  • BMI of 27 or higher with health conditions: People with overweight (BMI 27–29.9) may also qualify if they have at least one medical condition linked to extra weight. These conditions include:

    • Type 2 diabetes

    • High blood pressure

    • High cholesterol

    • Sleep apnea

The idea is that people who already face weight-related health risks may benefit most from these medicines.

Age Restrictions

Both semaglutide and Saxenda are approved mainly for adults. However, there are some differences:

  • Saxenda: Approved for adults and for teens aged 12 to 17 years who meet certain weight and health criteria. This makes Saxenda one of the few weight management drugs allowed for younger patients.

  • Semaglutide (Wegovy): Approved for adults. Recently, it has also been studied and allowed for some teens aged 12 years and older with obesity. Still, doctors are careful about prescribing it to younger patients and usually do so under specialist care.

Children under 12 years old are not eligible for either medication.

Medical History Considerations

A person’s medical history is very important. Even if their BMI qualifies, certain health conditions may make these medicines unsafe. Doctors review the following factors before prescribing:

  1. Thyroid Cancer and MEN2

    • People with a personal or family history of medullary thyroid carcinoma (MTC) should not take semaglutide or Saxenda.

    • They are also not safe for people with Multiple Endocrine Neoplasia syndrome type 2 (MEN2). Both drugs carry a warning about thyroid C-cell tumors in animal studies.

  2. Pancreatitis

    • If someone has had pancreatitis (inflammation of the pancreas), these medicines may raise the risk of it happening again. Doctors are cautious or avoid prescribing in these cases.

  3. Gallbladder Problems

    • Both semaglutide and Saxenda can increase the risk of gallstones and gallbladder disease. People with a history of gallbladder surgery or gallstones may need close monitoring.

  4. Stomach and Digestive Issues

    • Because these drugs slow down digestion, people with severe stomach or gut disorders may not tolerate them well.

  5. Other Health Issues

    • People with serious liver or kidney disease may not be good candidates. Doctors often check lab results before starting treatment.

Pregnancy and Breastfeeding

Neither semaglutide nor Saxenda is safe for use during pregnancy or breastfeeding. These drugs may harm an unborn baby or pass into breast milk. Women who are planning to become pregnant are advised to stop the medication several months in advance.

Mental Health Considerations

Some patients report mood changes while on these drugs. For this reason, people with certain mental health conditions may need extra monitoring. Doctors balance the risks and benefits carefully in these cases.

Lifestyle and Commitment Factors

Even if someone qualifies by BMI and health history, doctors also check if the person is ready to commit to lifestyle changes. These medications are most effective when paired with:

  • A healthy diet

  • Regular physical activity

  • Long-term follow-up with a healthcare provider

People looking for a “quick fix” without lifestyle changes are usually not good candidates.

is semaglutide like saxenda 3

How Are They Taken and How Often?

One of the biggest differences between semaglutide and Saxenda is how they are taken and how often they need to be used. Even though both medicines belong to the same group of drugs, called GLP-1 receptor agonists, the way people use them in daily life can feel very different. This section explains the dosing schedules, the methods of taking the drugs, how doctors usually increase the dose, and what this means for patients in practical terms.

Semaglutide: Weekly or Daily Options

Semaglutide comes in different forms, and the way it is taken depends on the brand.

  • Wegovy (semaglutide for weight management): This is a once-a-week injection. People use a prefilled pen and inject it under the skin, usually in the stomach, thigh, or upper arm. The same day each week is chosen, and it can be morning or evening, with or without food.

  • Ozempic (semaglutide for type 2 diabetes): Also given as a once-weekly injection, with very similar instructions to Wegovy. Even though it was made for diabetes, some doctors prescribe it “off-label” for weight loss.

  • Rybelsus (oral semaglutide): This is the only pill form of semaglutide. It must be taken once daily, at least 30 minutes before eating or drinking anything other than a small sip of water. Patients must wait before having breakfast or taking other medications, because food and liquids can reduce how well the pill works.

The weekly injection option is often seen as more convenient because people only have to remember it once a week. However, some may prefer pills to avoid needles, even though the pill has stricter rules for timing and absorption.

Saxenda: Daily Injection

Saxenda, which contains liraglutide, is only available as a once-daily injection. Patients use a prefilled pen to inject the medicine under the skin, usually in the stomach, thigh, or upper arm, much like semaglutide injections. The key difference is that it has to be done every single day, around the same time.

Because Saxenda is injected daily, people may find it harder to keep up with compared to a once-weekly drug like semaglutide. On the other hand, some patients prefer daily routines because it becomes a habit, like brushing teeth, and may feel easier to remember than a weekly schedule.

Dose Titration: Starting Low and Going Slow

Both semaglutide and Saxenda must be started at a low dose and increased gradually. This process is called titration. The main reason is to lower the chance of side effects, especially stomach problems like nausea or vomiting.

  • Wegovy: Usually starts at 0.25 mg once weekly, and the dose is raised step by step over 16 to 20 weeks until it reaches the full maintenance dose of 2.4 mg once weekly.

  • Ozempic: Starts at 0.25 mg weekly, then slowly goes up, with most patients staying at 0.5 mg or 1 mg weekly for diabetes. Some may use up to 2 mg weekly.

  • Rybelsus: Starts at 3 mg daily for one month, then increases to 7 mg daily, and may go up to 14 mg daily depending on response.

  • Saxenda: Starts at 0.6 mg daily, then increases weekly until reaching the full dose of 3.0 mg daily. This usually takes five weeks.

Titration schedules are important because going up too quickly can make the medicine very hard to tolerate. Doctors will often adjust the speed of titration if someone has strong side effects.

Practical Considerations for Patients

The difference in how semaglutide and Saxenda are taken has real-life effects on patients.

  • Convenience: Many people find a weekly shot easier to manage than a daily one. With semaglutide, forgetting one dose still allows some flexibility, since the next dose can be given within a few days. Saxenda requires daily discipline, which may feel burdensome.

  • Lifestyle Fit: Oral Rybelsus appeals to people who dislike injections, but it requires strict rules around food timing. For people with busy mornings or who already take multiple medicines, this can be tricky.

  • Storage: Both semaglutide pens and Saxenda pens need refrigeration before use, though they can usually be kept at room temperature for a limited time once opened. This can be important for people who travel.

  • Needle Use: Both injection types use very small, thin needles. Most patients find them easy to use and less painful than expected, but there can still be hesitancy with daily injections.

Semaglutide and Saxenda are used in different ways. Semaglutide is usually given once a week by injection, or once daily by pill in the case of Rybelsus. Saxenda requires a daily injection. Both drugs need to be started at low doses and raised slowly to reduce side effects. These differences in dosing schedule, method of use, and lifestyle impact are important to consider when doctors and patients decide which treatment is the best fit.

Cost and Insurance Coverage

When people think about taking medicines like semaglutide (Wegovy, Ozempic, Rybelsus) or Saxenda, one of the biggest questions is: how much do they cost, and will insurance help pay for them? These medicines are effective for weight loss and diabetes care, but they are also known to be expensive. Understanding the financial side is important before starting treatment.

Average Retail Prices

Both semaglutide and Saxenda are brand-name drugs. That means they do not have generic or cheaper copies available yet. Because of this, the retail prices are very high compared to many other medicines.

  • Semaglutide (Wegovy for weight loss): In the United States, the monthly cost without insurance can be around $1,300 to $1,500. The price may change depending on the pharmacy and location, but this range is common.

  • Semaglutide (Ozempic for diabetes): The price is usually similar, often $900 to $1,200 per month if paid out of pocket. Even though Ozempic is used for diabetes, many people seek it for weight loss, but insurance usually does not cover it for that reason.

  • Saxenda (liraglutide for weight loss): Saxenda’s monthly cost is also very high, averaging $1,300 to $1,400 without insurance.

These costs are for people paying full price. For many, this is too expensive to afford long-term. That is why insurance coverage and discount programs are so important.

Insurance Coverage Differences

Whether insurance covers semaglutide or Saxenda depends on why you are taking the medicine and your insurance plan rules.

  • For diabetes: Insurance companies are more likely to cover Ozempic (semaglutide) or Victoza (liraglutide, the diabetes version of Saxenda). Because these medicines are approved to treat type 2 diabetes, health plans usually include them in their drug lists. Patients may still have to pay a co-pay, which could range from $25 to several hundred dollars per month depending on the plan.

  • For obesity: Coverage is less certain. Wegovy (semaglutide for weight loss) and Saxenda (liraglutide for weight loss) are FDA-approved for chronic weight management. But not all insurance companies recognize obesity treatment as a covered benefit. Some employers choose not to include weight-loss drugs in their health plans because of the cost. This means some people have no coverage at all, while others may have partial coverage.

Even when insurance does cover the medicine, patients often must meet certain rules before approval. These rules are called prior authorization requirements. For example, an insurance company may ask:

  • What is your BMI?

  • Do you have obesity-related conditions such as diabetes, high blood pressure, or sleep apnea?

  • Have you tried diet and exercise before starting the drug?

If you do not meet the insurance company’s criteria, coverage may be denied.

Patient Assistance Programs

Because the out-of-pocket cost is so high, drug companies sometimes offer help. Both Novo Nordisk (maker of Wegovy, Ozempic, and Saxenda) and other organizations run programs to reduce costs. These programs include:

  1. Savings cards or copay cards: For people with commercial insurance, the company may lower the monthly cost. For example, some patients may pay as little as $25 per month if their insurance covers the drug, though there are limits.

  2. Patient assistance programs (PAPs): These are for people without insurance or with very low income. If you qualify, you might get the medicine for free or at a much lower price.

  3. Discount programs and pharmacies: Some mail-order or specialty pharmacies offer lower cash prices, but this still tends to be expensive compared to insured rates.

Out-of-Pocket Expectations

Without insurance, patients can expect to pay over $12,000 to $16,000 per year for semaglutide or Saxenda. Even with insurance, costs can still add up. Some people face high deductibles, meaning they must pay thousands of dollars first before insurance begins to cover the medicine. Others may face higher co-pays because these medicines are often placed in the “specialty drug” category.

Global Cost Differences

It is also worth noting that the cost of semaglutide and Saxenda can be very different outside the United States. In countries with national health systems, like Canada or many European nations, the government negotiates lower drug prices. In these places, patients may pay much less, sometimes only a small monthly fee. But in the U.S., where prices are not controlled in the same way, costs are usually much higher.

Why the Costs Are So High

These medicines are expensive for several reasons:

  • They are newer drugs with no generic versions yet.

  • The companies invested heavily in research, trials, and marketing.

  • They are in high demand, especially for weight loss, which has increased shortages and raised costs.

Until patents expire and generic versions become available, prices are expected to remain high.

The cost of semaglutide and Saxenda is one of the biggest barriers for patients. While both can be life-changing for weight loss and health improvement, not everyone can afford them. Insurance may cover them for diabetes more reliably than for obesity. Patients should check with their insurance provider, ask their doctor for help with prior authorizations, and explore savings programs offered by the manufacturers.

is semaglutide like saxenda 4

Change Your Life Today For Only $249/month

Find out if you qualify
No Hidden Fees, No Contracts

Long-Term Use and Safety Data

When people think about starting semaglutide (Wegovy, Ozempic, Rybelsus) or Saxenda (liraglutide), one of the biggest questions is: How safe are these medicines if I take them for a long time? These drugs are not designed as short, one-time treatments. They are meant for ongoing use in managing weight and, in some cases, type 2 diabetes. Below, we will break down what is currently known about long-term use, safety, and what happens if you stop treatment.

How Long Do People Usually Take These Medicines?

Semaglutide and Saxenda are considered chronic therapies. This means doctors prescribe them with the idea that patients will need to take them for months or even years. Obesity is a long-term health condition, similar to high blood pressure or diabetes, and it often requires ongoing treatment.

  • Saxenda (liraglutide): Most clinical trials studied people for about 56 weeks (a little over a year). Many participants stayed on the medicine for the full trial, while others stopped because of side effects. Real-world data suggests some people take it for several months to a few years.

  • Semaglutide (Wegovy for weight management): The key STEP trials followed patients for about 68 weeks (a year and four months). Some ongoing studies are tracking patients for two years or longer. Many doctors expect patients may need semaglutide for long-term management if they want to keep the weight off.

What Happens After Stopping the Medicine?

One important finding from research is that weight regain is common after stopping treatment.

  • In one large semaglutide trial, patients lost an average of about 15% of their body weight after more than a year of treatment. However, when the medicine was stopped, many participants regained much of that weight within 12 months.

  • Similar results were seen with Saxenda. When patients stopped taking it, they often regained a significant amount of weight that they had lost.

This shows that these medications work best when continued. Just like blood pressure medicines stop working once discontinued, weight-loss medicines may also lose their effect when treatment ends. Doctors often describe obesity as a “chronic disease” that may need long-term therapy.

Long-Term Safety Evidence

Gastrointestinal Effects

The most common side effects over the long term are stomach-related: nausea, diarrhea, vomiting, and constipation. For many people, these symptoms improve after the first few weeks, but for others, they remain and may lead to stopping the medicine.

Gallbladder Problems

Both semaglutide and Saxenda increase the risk of gallbladder disease, such as gallstones or gallbladder inflammation. This risk seems to grow the longer people stay on the medicine, especially if they lose weight quickly.

Pancreatitis

There is a small but important concern about pancreatitis (inflammation of the pancreas). While rare, it can be serious. People with a past history of pancreatitis are often advised not to use these drugs. Ongoing studies continue to monitor how often this happens in long-term users.

Thyroid Concerns

Animal studies showed an increased risk of thyroid C-cell tumors with both drugs. Because of this, neither semaglutide nor Saxenda is recommended for people with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 (MEN2). So far, this risk has not been confirmed in humans, but long-term research is still underway.

Heart and Metabolic Health

One of the most encouraging findings is the benefit these medicines may bring to heart and metabolic health:

  • Semaglutide: Studies in people with diabetes show reduced risk of major heart problems like heart attack and stroke. Research is now expanding into people who take it mainly for obesity.

  • Saxenda: Smaller studies suggest some benefit for heart risk factors, such as blood pressure and cholesterol, but the evidence is not as strong as for semaglutide.

These results show that long-term use may not only help with weight management but also protect against diseases linked to obesity.

Ongoing Studies and Research

Right now, many long-term studies are in progress:

  • Semaglutide (SELECT trial): A major study looked at cardiovascular outcomes in people with overweight or obesity but no diabetes. Early results suggest semaglutide lowers the risk of heart events.

  • Saxenda: Long-term data is more limited compared to semaglutide, but post-marketing studies continue to monitor safety.

Researchers are also studying how long people need to stay on these medicines to maintain benefits, and whether lower doses could work for maintenance.

The Role of Lifestyle in Long-Term Use

It’s important to know that medicine works best when combined with lifestyle changes. People who continue healthy eating habits and physical activity while on semaglutide or Saxenda are more likely to keep weight off and reduce health risks. Without these changes, weight regain is even more likely if treatment is stopped.

Conclusion

Semaglutide and Saxenda are two of the most widely discussed medications for weight management today. Both belong to the same group of medicines called GLP-1 receptor agonists, which means they act on the same hormone pathways in the body. They work by slowing down digestion, helping people feel full sooner, and reducing appetite. Because of this shared mechanism, they are often compared. But when you look closely, there are several differences in effectiveness, dosing, side effects, and cost that are important to understand before deciding which treatment may be right for someone.

One of the most significant differences between semaglutide and Saxenda is their effectiveness in supporting weight loss. In clinical studies, people taking semaglutide generally lost a greater percentage of their body weight compared to those on Saxenda. For example, in trials that lasted about a year, patients using semaglutide lost an average of 12–15% of their body weight, while those using Saxenda lost about 6–8%. This is a noticeable gap, and it shows that semaglutide tends to be more powerful in terms of weight reduction. This does not mean Saxenda is not effective, but rather that semaglutide has shown a stronger impact in research.

The difference in how these medicines are taken also plays a role in how people use them over time. Saxenda must be injected every day, while semaglutide is given once a week by injection, or in some forms, taken as a pill each day. The less frequent dosing of semaglutide makes it easier for many people to stay consistent with treatment. Daily injections can sometimes be harder to manage, especially for those who already take several other medications or have busy schedules. The convenience of a weekly dose is one reason semaglutide is often preferred when patients and doctors compare the two.

Side effects are another important area where the two drugs overlap and differ. Both medications can cause nausea, vomiting, diarrhea, or constipation, especially in the first weeks of use when the body is adjusting. These effects usually improve over time as the dose is slowly increased. However, semaglutide sometimes causes stronger stomach-related side effects because it stays in the body longer and is more potent. Still, because semaglutide is taken less often, many patients find it easier to handle than daily injections of Saxenda. Serious side effects, such as inflammation of the pancreas, gallbladder problems, or a potential risk for thyroid tumors seen in animal studies, are rare but possible with both drugs. Doctors carefully review a patient’s health history to make sure the benefits outweigh the risks.

Cost is another area that matters to most patients. Both Saxenda and semaglutide are expensive medications without generic options. On average, the monthly cost of these treatments can range from $1,000 to $1,300 in the United States if a person does not have insurance coverage. Insurance plans vary widely in whether they cover weight-loss medications. Some patients may receive partial coverage, while others must pay the full amount out of pocket. Patient assistance programs are available, but access can be limited depending on income, insurance status, or location. Because of these financial factors, the decision between semaglutide and Saxenda often depends not only on medical effectiveness but also on affordability and access.

Long-term use is another key question. Both medications are meant for chronic use, not short-term treatment. Studies show that when people stop taking either drug, weight is often regained. This means that for many patients, these medications are best used as ongoing therapy, combined with lifestyle changes like healthier eating and more physical activity. The good news is that semaglutide and Saxenda may also provide additional health benefits beyond weight loss, such as lowering blood sugar levels and improving heart health markers. More research is still underway to understand these long-term effects.

When you put all of these points together, the comparison between semaglutide and Saxenda becomes clearer. Both medicines belong to the same family of treatments and work in similar ways. But semaglutide has been shown to lead to greater average weight loss, is easier to take because of weekly dosing, and may offer stronger long-term results. Saxenda, while effective, requires daily injections and may not achieve the same level of weight loss in most patients. Side effects are common for both, with semaglutide sometimes being more intense but often easier to tolerate because of the less frequent dosing. The cost is high for both, and access depends heavily on insurance or assistance programs.

In the end, the choice between semaglutide and Saxenda is not simple. It depends on a patient’s health goals, medical history, comfort with injections, ability to tolerate side effects, and financial situation. Both medications require guidance from a healthcare professional, who can help weigh the risks and benefits. While they share many similarities, their differences are significant, and understanding these details helps patients and doctors make the best decision for safe and effective long-term treatment.

Research Citations​

Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., … Wilding, J. P. H. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892

Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., … Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183

Rubino, D. M., Greenway, F. L., Khalid, U., O’Neil, P. M., Rosenstock, J., Sørrig, R., … Garvey, W. T. (2022). Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: The STEP 8 randomized clinical trial. JAMA, 327(2), 138–150. https://doi.org/10.1001/jama.2021.23619

Capehorn, M. S., Catarig, A.-M., Furberg, J. K., Janež, A., Price, H. C., Tadayon, S., … Marre, M. (2020). Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in type 2 diabetes (SUSTAIN 10). Diabetes & Metabolism, 46(2), 100–109. https://doi.org/10.1016/j.diabet.2019.101117

Garvey, W. T., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen, J. W., Frias, J. P., … Wilding, J. P. H. (2022). Two-year effects of semaglutide in adults with overweight or obesity (STEP 5). Nature Medicine, 28(10), 2083–2091. https://doi.org/10.1038/s41591-022-02026-4

Wadden, T. A., Bailey, T. S., Billings, L. K., Kapitza, C., Claudius, B., Roeggen, I., … Rubino, D. (2021). Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity (STEP 3). JAMA, 325(14), 1403–1413. https://doi.org/10.1001/jama.2021.1831

Weghuber, D., Barrett, T., Barrientos-Pérez, M., Gies, I., Hesse, D., Jeppesen, O. K., … Arslanian, S.; STEP TEENS Investigators. (2022). Once-weekly semaglutide in adolescents with obesity. New England Journal of Medicine, 387(24), 2245–2257. https://doi.org/10.1056/NEJMoa2208601

Trujillo, J. M., Nuffer, W., & Smith, B. (2021). GLP-1 receptor agonists: An updated review of head-to-head clinical studies. Therapeutic Advances in Endocrinology and Metabolism, 12, 2042018821997320. https://doi.org/10.1177/2042018821997320

Collins, L., & Costello, R. A. (2024). Glucagon-Like Peptide-1 Receptor Agonists. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK551568/

Gasoyan, H., He, H., Szekely, I., Qato, D. M., Shaffer, J. A., & Athavale, A. (2024). One-year weight reduction with semaglutide or liraglutide in clinical practice. JAMA Network Open, 7(1), e2352188. https://doi.org/10.1001/jamanetworkopen.2023.52188

Change Your Life Today For Only $249/month

Find out if you qualify
No Hidden Fees, No Contracts

Questions and Answers: Is Semaglutide Like Saxenda

No. Semaglutide and Saxenda (liraglutide) are different medications, but both belong to the same class of drugs called GLP-1 receptor agonists.

Yes. Both mimic the GLP-1 hormone, which helps regulate appetite and blood sugar. They slow stomach emptying, increase satiety, and reduce food intake.

The main difference is their formulation and dosing. Semaglutide (e.g., Wegovy, Ozempic) is usually taken once weekly, while Saxenda is injected daily.

Yes. Saxenda is FDA-approved for chronic weight management. Semaglutide (at the higher dose brand Wegovy) is also FDA-approved for weight loss, while Ozempic (lower-dose semaglutide) is approved for type 2 diabetes but often used off-label for weight management.

Studies suggest semaglutide (Wegovy) leads to greater average weight loss compared to Saxenda.

Yes. Both can cause nausea, vomiting, diarrhea, constipation, and stomach discomfort. Side effects may vary in intensity depending on the dose and individual tolerance.

Yes, but in different contexts. Saxenda is primarily for weight management. Liraglutide at a lower dose (Victoza) is used for type 2 diabetes. Semaglutide (Ozempic, Rybelsus) is approved for type 2 diabetes.

Largely yes. Both carry warnings about possible risks of thyroid C-cell tumors (seen in rodents), pancreatitis, gallbladder problems, and gastrointestinal issues.

Semaglutide (Wegovy/Ozempic) is injected once weekly, while Saxenda requires a daily injection.

It depends on patient needs and response. Semaglutide may be preferred for its once-weekly dosing and stronger weight loss results, but Saxenda remains an option for those who tolerate it better or have insurance coverage limitations.

Jay Flottman

Dr. Jay Flottman

Dr. Jay Flottmann is a physician in Panama City, FL. He received his medical degree from University of Texas Medical Branch and has been in practice 21 years. He is experienced in military medicine, an FAA medical examiner, human performance expert, and fighter pilot.
Professionally, I am a medical doctor (M.D. from the University of Texas Medical Branch at Galveston), a fighter pilot (United States Air Force trained – F-15C/F-22/AT-38C), and entrepreneur.

Skip to content